1. Home
  2. COGT vs CBNK Comparison

COGT vs CBNK Comparison

Compare COGT & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • CBNK
  • Stock Information
  • Founded
  • COGT 2014
  • CBNK 1974
  • Country
  • COGT United States
  • CBNK United States
  • Employees
  • COGT N/A
  • CBNK N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • CBNK Major Banks
  • Sector
  • COGT Health Care
  • CBNK Finance
  • Exchange
  • COGT Nasdaq
  • CBNK Nasdaq
  • Market Cap
  • COGT 545.3M
  • CBNK 471.8M
  • IPO Year
  • COGT 2018
  • CBNK 2018
  • Fundamental
  • Price
  • COGT $4.37
  • CBNK $27.63
  • Analyst Decision
  • COGT Buy
  • CBNK Hold
  • Analyst Count
  • COGT 7
  • CBNK 1
  • Target Price
  • COGT $14.17
  • CBNK $35.00
  • AVG Volume (30 Days)
  • COGT 1.7M
  • CBNK 59.2K
  • Earning Date
  • COGT 05-06-2025
  • CBNK 04-25-2025
  • Dividend Yield
  • COGT N/A
  • CBNK 1.45%
  • EPS Growth
  • COGT N/A
  • CBNK N/A
  • EPS
  • COGT N/A
  • CBNK 2.12
  • Revenue
  • COGT N/A
  • CBNK $170,671,000.00
  • Revenue This Year
  • COGT N/A
  • CBNK $43.45
  • Revenue Next Year
  • COGT N/A
  • CBNK $8.33
  • P/E Ratio
  • COGT N/A
  • CBNK $13.03
  • Revenue Growth
  • COGT N/A
  • CBNK 8.71
  • 52 Week Low
  • COGT $3.72
  • CBNK $19.02
  • 52 Week High
  • COGT $12.61
  • CBNK $32.88
  • Technical
  • Relative Strength Index (RSI)
  • COGT 34.56
  • CBNK 49.01
  • Support Level
  • COGT $4.12
  • CBNK $26.20
  • Resistance Level
  • COGT $5.09
  • CBNK $28.32
  • Average True Range (ATR)
  • COGT 0.54
  • CBNK 1.22
  • MACD
  • COGT -0.02
  • CBNK 0.10
  • Stochastic Oscillator
  • COGT 23.90
  • CBNK 76.36

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.

Share on Social Networks: